Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)

This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic

Saved in:
Bibliographic Details
Published inJournal of cancer research and clinical oncology Vol. 146; no. 11; pp. 3075 - 3078
Main Authors Ivanyi, Philipp, Grüllich, Carsten, Kroeger, Nils, Gauler, Thomas, Johannsen, Manfred, Bedke, Jens, Grünwald, Viktor
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.11.2020
Subjects
Antineoplastic Agents - therapeutic use
Betacoronavirus
Cancer Research
Carcinoma, Renal Cell - drug therapy
Coronavirus Infections
COVID-19
Hematology
Humans
Internal Medicine
Kidney Neoplasms - drug therapy
Letter to the Editor
Medicine
Medicine & Public Health
Oncology
Pandemics
Pneumonia, Viral
Practice Guidelines as Topic
SARS-CoV-2
Online AccessGet full text

Cover

More Information
Summary:This letter summarizes recommendations from the interdisciplinary working group of renal tumors (IAGN) of the German Cancer Society for the systemic treatment of advanced/metastatic renal cell carcinoma in the context of the current SARS-CoV-2 pandemic
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0171-5216
1432-1335
DOI:10.1007/s00432-020-03341-4